Trial intelligence / Profile preview

Thermography Study of Sildenafil Cream 3.6% in Healthy Women

NCT05765487Phase 1Completed

Sponsor
Daré Bioscience, Inc.
Start
May 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in Sexual Arousal Disorder comparing Sildenafil Cream, Placebo Cream and Vehicle Cream (3 arms). Primary endpoint: Difference in vulvar blood flow at 14 days. Started May 2023; status: completed.

02

Drugs

sildenafil
03

Conditions

Sexual Arousal Disorder

Beyond the preview

Go deeper on NCT05765487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05765487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call